#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mark Pollack Email
SVP, Global Medical Affairs . Sage Therapeutics
Cambridge, MA
LocationPrimary Email
How to contact Mark Pollack
Join and see Mark's contact info for free!Current Roles
Employees:
768Revenue:
$97.7MAbout
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage's lead product candidate, ZULRESSO(TM) (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.Sage Therapeutics Address
215 First StreetCambridge, MA
United States